Clinical Trials
27 trialsROME
Fondazione per la Medicina Personalizzata
Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin
Gruppo Oncologico Italiano di Ricerca Clinica
MULAN
Fudan University
Efficacy and Safety of Precision Therapy in Refractory Tumor
Shanghai Changzheng Hospital
ALTER-UC-001
Fudan University
Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone
Thomas Jefferson University
MetNET1
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin
The Netherlands Cancer Institute
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
BIOMEDE
Gustave Roussy, Cancer Campus, Grand Paris
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Shanghai Jiao Tong University School of Medicine
TRON
Cardiff University
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
University of Kansas Medical Center
Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer
M.D. Anderson Cancer Center
Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Sinai Hospital of Baltimore
Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study
Peking University Cancer Hospital & Institute
MIRACLE
ChineseAMS
Exemestane Plus Everolimus for Hormone-receptor Positive Metastatic Breast Cancer
Organisation for Oncology and Translational Research
Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer
National Cancer Institute (NCI)
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma
Hospital Santa Marcelina
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas
Hospital Santa Marcelina
RADAR
GBG Forschungs GmbH
EPOCAL
Azienda Ospedaliera di Padova
Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy
Organisation for Oncology and Translational Research
CRAD001T
Ratchavithi Hospital
RADiChol
Austin Health
Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer
Sheba Medical Center